Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience

Bone Marrow Transplantation

Volumn 45, Issue 5, 2010, Pages 895-900

  Majumdar, S ^a   Robertson, Z ^a   Robinson, A ^a   Starnes, S ^a   Iyer, R ^a   Megason, G ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Hematopoietic stem cell transplantation; Long term outcome; Sickle cell disease

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; ATAXIA; BETA THALASSEMIA; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; CHIMERA; CLINICAL ARTICLE; DONOR; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MALE; NONMYELOABLATIVE CONDITIONING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SEIZURE; SICKLE CELL ANEMIA; UMBILICAL CORD BLOOD;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 77952427892     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.244     Document Type: Article

References (17)

1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;23:1639-1644.
2. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-508.
3. Serjeant GR. Natural history and determinants of clinical severity of sickle cell disease. Curr Opin Hematol 1995;2:103-108 Review.
4. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-610.
5. Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 2005;106:2269-2275.
6. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
7. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000;95:1918-1924.
8. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998;22:1-6.
9. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007;110:2749-2756 Epub 2 July 2007.
10. Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995;85:879-884.
11. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-828 (Review).
12. Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003;102:802-809.
13. Schoenberg JB, Beck GJ, Bouhuys A. Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol 1978;33:367-393.
14. Woodard P, Helton KJ, Khan RB, Hale GA, Phipps S, Wang W et al. Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 2005;129:550-552.
15. Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP et al. Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow TranMatched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007;137:479-485.
16. Gaziev J, Sodani P, Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone Marrow Transplant 2008;42: S41.
17. Soliman AT, elZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr 1999;45:23-30.